Low rates of treatment for hypertension, dyslipidemia and diabetes in schizophrenia: Data from the CATIE schizophrenia trial sample at baseline☆
To access this article, please choose from the options below
☆ Supported by NIMH grant #N01MH90001.
PII: S0920-9964(06)00298-2
doi:10.1016/j.schres.2006.06.026
© 2006 Elsevier B.V. All rights reserved.
